PharmiWeb.com - Global Pharma News & Resources
06-Nov-2018

T-Cell Immunotherapy Markets to 2024: Lucrative Opportunities from Rapidly Increasing R&D Activities - ResearchAndMarkets.com

The "T-Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.


The report predicts the global t-cell immunotherapy market to grow with a healthy CAGR over the forecast period of 2018-2024.
The study on t-cell immunotherapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.


Market Dynamics

Drivers

  • Growing Occurrence of Cancer in both Children as well as in Adults
  • On-Going Development to Improve Existing Therapies

Restraints

  • Neurological Problems Associated with T-cell Immunotherapy

Opportunities

  • Rapidly Increasing Research & Development Activities
  • Technological Advancement in Cancer Treatment

Segments Covered

Mechanism of Action

  • Active Immunotherapy
  • Passive Immunotherapy

Type of Therapy

  • CAR-T
  • TCR
  • TIL

Product Class

  • Monoclonal Antibodies
  • Oncolytic Virus Therapy
  • Bispecific Antibodies
  • Cytokines

Companies Profiled

  • Adaptimmune Therapeutics
  • Bluebird Bio
  • Innovative Cellular Therapeutics
  • Novartis
  • Sinobioway Cell Therapy
  • Cellectis
  • CARsgen Therapeutics
  • Autolus
  • Celgene

Key Topics Covered

1. Preface

2. Executive Summary

3. Global T-Cell Immunotherapy Market Overview

4. T-Cell Immunotherapy Market Macro Indicator Analysis

5. Global T-Cell Immunotherapy Market by Mechanism of Action

6. Global T-Cell Immunotherapy Market by Type of Therapy

7. Global T-Cell Immunotherapy Market by Product Class

8. Global T-Cell Immunotherapy Market by Region

9. Company Profiles and Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/9dfcs5/tcell?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181106005556/en/

Editor Details

Last Updated: 06-Nov-2018